Event Calendar

Previous month Previous day Next day Next month
By Year By Month By Week Today Search Jump to month

 

Regional Symposium (UPMC)      
Saturday, March 07, 2015 8:15 – 12:00      

Navigating the New Era of IPF: Collaborative Patient Care

Saturday, March 7, 2015
8:15 AM–NOON
University of Pittsburgh
Simmons Center
Conference Room BST-100 South
3459 Fifth Avenue
Pittsburgh, Pennsylvania

Register


Hosted by the University of Pittsburgh Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease at UPMC

Sponsored by the University of Pittsburgh School of Medicine, The France Foundation, and the Pulmonary Fibrosis Foundation

AGENDA TOPICS

  • Exploring ILDs
  • Diagnosing IPF
  • Pathophysiology of IPF and Recent Clinical Trials
  • Comorbidities and Complications of IPF
  • Patient Monitoring, Management, and the Coordination of Care
  • Problem-based Learning Cases

UNIVERSITY OF PITTSBURGH FACULTY
Kathleen O. Lindell, PhD, RN
Kevin F. Gibson, MD
Daniel J. Kass, MD
Luis A. Ortiz, MD
Kristen L. Veraldi, MD, PhD, FCCP

Target Audience:
 This activity is intended for physicians, surgeons, critical care clinicians, advanced practice nurses, and other health care professionals involved in the diagnosis and management of patients with IPF.

Statement of Need: Idiopathic pulmonary fibrosis (IPF) is characterized by progressive worsening of dyspnea and lung function and is associated with a poor prognosis. Today, median survival time from diagnosis of IPF is two to five years. In 2011 an international committee of the American Thoracic Society (ATS) and European Respiratory Society (ERS) published updated guidelines for the diagnosis and management of patients with IPF. There are still challenges for health care providers who treat patients with IPF. These include acute exacerbations and comorbid conditions commonly seen in patients with IPF. In October 2014 the FDA approved two new drugs for the treatment of IPF. These therapies transform the management of IPF and present new options for practitioners and patients.

Educational Activity Learning Objectives 
Upon completion of this course, the participants should be able to:

  • Explain the considerations associated with clinical evaluation, imaging, and surgical biopsy, in terms of differentially diagnosing IPF
  • Identify opportunities for interdisciplinary collaboration and consultation and key aspects of guideline recommendations that can facilitate early and accurate IPF diagnosis
  • Summarize the current understanding of the IPF disease process and strategies that can help measure disease progression and treatment response
  • Identify approaches to IPF management that are covered in current guidelines, taking into account the strength of relevant recommendations
  • Formulate a plan, based on available data and expert consensus, for addressing acute exacerbations of IPF
  • Evaluate clinical trial data on available and emerging treatments for IPF and potential application to practice
  • Formulate a plan for regular and relevant communication with and education of patients and families regarding both pharmacologic and nonpharmacologic aspects of care
  • Explain the impact and treatment of common comorbidities of IPF
  • Identify opportunities for referral to others as part of the multidisciplinary IPF management plan

CME Accreditation and Designation Statement: The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other health care professionals are awarded 0.3 continuing educational units (CEU’S) which are equal to 3.2 contact hours.

Disclaimer Statement: The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

Disclosure: The University of Pittsburgh School of Medicine, The France Foundation and the Pulmonary Fibrosis Foundation adhere to ACCME Essential Areas, Standards, and Policies regarding industry support of continuing medical education. Disclosure of the planning committee, content reviewers, and faculty’s commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

Resolution of Conflicts of Interest: In accordance with the ACCME Standards for Commercial Support of CME, The University of Pittsburgh School of Medicine, The France Foundation and the Pulmonary Fibrosis Foundation will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

The France Foundation fully complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant of this activity is in need of accommodation, please submit written requests via fax to 860-434-5390.

Media Disclosure: Your registration, attendance at, and/or participation in this meeting constitutes consent to being photographed, videotaped, or recorded during the meeting by The France Foundation, its educational collaborators, or anyone authorized on behalf of these organizations. You further authorize, without any compensation paid to you, the use of any photographs, videos, or recordings that contain your likeness, image, or voice in any educational, informational, commercial, or promotional materials produced and/or distributed by The France Foundation, its educational collaborators, or anyone authorized by these organizations, as well as on any Internet sites maintained by any of these entities. Images/recordings used for these purposes will not be sold, and no personal information about you or the subject (other than event location and date) will be included in the production of any material.

Acknowledgement of Commercial Support: We gratefully acknowledge support from the following to support this activity: Intermune. Intermune is providing the educational grant to support the promotion of this meeting, but in no way has any input or guidance on content presented at this meeting.

The University of Pittsburgh is an affirmative action, equal opportunity institution.

Event Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.


Venue Information:
Location:
University of Pittsburgh Medical Center
Street: 3459 Fifth Avenue
City: Pittsburgh
State: PA

ISO Start Time: 2015-03-07T08:15:00